Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma

Figure 2

Prognostic analysis of the five-gene signature model in the TCGA and GEO cohort. (a) The distribution and median value of the risk scores in the TCGA cohort. (b) The distributions of OS status, OS, and risk score in the TCGA cohort. (c) PC plot of the TCGA cohort. (d) t-SNE analysis of the TCGA cohort. (e) Kaplan-Meier curves for the OS of patients in the high-risk group and low-risk group in the TCGA cohort. (f) The AUC of time-dependent ROC curves verified the prognostic performance of the risk score in the TCGA cohort. (g) Kaplan-Meier curves for the OS of patients in the high-risk group and low-risk group in the GEO (GSE119043) cohort. (h) The AUC of time-dependent ROC curves verified the prognostic performance of the risk score in the GEO (GSE119043) cohort.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)